Non-invasive blood glucose monitoring by interferometry

Optics: measuring and testing – By light interference – For refractive indexing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C356S450000

Reexamination Certificate

active

06836337

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to glucose monitoring, and more specifically, to apparatus and methods for monitoring glucose using interferometry.
2. Description of the Related Art
Diabetics are advised to closely monitor the concentration of glucose in their bloodstream. If the concentration is outside of a normal healthy range, the patient needs to adjust his or her insulin dosage or sugar intake to counter the risk of diabetic complications. Current monitoring methods involve drawing blood from the patient several times a day, which is costly, painful, and poses the risk of infection. As a result, many diabetics test their blood glucose less frequently than would be desirable, increasing the possibility of diabetic related health problems. Thus, what is needed is a painless, non-invasive approach for determining the glucose level within the bloodstream.
SUMMARY OF THE INVENTION
One aspect of the invention comprises a method of measuring glucose levels in blood of a living being having an eye. The eye comprises a cornea and a lens, which together form an anterior chamber. The eye further comprises an iris and aqueous humor in the anterior chamber of the eye. The aqueous humor has an index of refraction that is correlated to the glucose level in the blood. To measure the glucose levels in the blood, two substantially coherent beams of light are propagated through the cornea to illuminate a region of the iris. The two substantially coherent beams of light propagate through the aqueous humor to reach the iris. The two beams are overlapped on the region of the iris. These two beams are sufficiently coherent so as to produce an interference pattern in this region of the iris where they overlap. The interference pattern comprises a plurality of fringes having a spatial arrangement that depends on the index of refraction of the aqueous humor. The interference pattern is imaged onto a light sensitive optical detector, and the glucose level in the blood is determined from the spatial arrangement of the fringes in the interference pattern.
Another aspect of the invention comprises an apparatus for monitoring glucose fluctuations by measuring optical properties of an eye. The apparatus comprises a light source which emits a beam of light, an optical element, an optical detector and imaging optics. The optical element is situated to receive this beam of light from the light source and to split the beam of light into first and second probe beams that propagate along respective first and second optical paths. The apparatus further includes at least one optical element in one of the optical paths to alter the optical path such that first and second probe beams intersect at a target plane. The optical detector and imaging optics are arranged to image the target plane onto the optical detector.
Another aspect of the invention comprises a method of monitoring glucose levels in blood of a living being having an eye. In this method, light is propagated through a portion of the eye comprising aqueous humor having an index of refraction that varies with glucose concentration. Phase information associated with the light is obtained through optical interference. The phase information depends at least in part on the index of refraction of the aqueous humor. The phase information is used to determine the glucose levels in the blood.
Yet another aspect of the invention comprises an alignment apparatus for lateral aligning an eye with respect to the apparatus. The apparatus comprises a central light source, a partially reflecting concave mirror, and first and second offset light sources. The partially reflecting concave mirror has an optical axis passing therethrough. The central light source is centrally disposed along this optical axis such that at least a portion of the light from the central light source propagates through the partially reflecting concave mirror along the optical axis. The first and second offset light sources are disposed in a plane passing through the optical axis. The first and second offset light sources are on opposite sides of the optical axis and emit light at an oblique angle toward the optical axis.
Still another aspect of the invention comprises an method of aligning a device with respect to a cornea wherein the cornea has a substantially spherical curvature defined by a center of curvature. In this method light is propagated toward the cornea. This light has substantially spherical wavefronts defined by a center of curvature that is substantially coincident with the center of curvature of the cornea. A portion of the light from the cornea is retrorefect, collected, and focusing onto an optical detector having a photosensitive area. When the center of curvature of the wavefronts is substantially coincident with the center of curvature of the eye, the light focused on the photosensitive area has a different intensity than when the respective centers of curvature are non-coincident.


REFERENCES:
patent: 4653855 (1987-03-01), Birnbach et al.
patent: 5064286 (1991-11-01), Ai et al.
patent: 5710630 (1998-01-01), Essenpreis et al.
patent: 5896198 (1999-04-01), Chou et al.
patent: 5923425 (1999-07-01), Dewa et al.
patent: 6327037 (2001-12-01), Chou et al.
Jongsma F.H.M. et al., “Review and Classification of Corneal Topographers”, Lasers Med Sci, 1999, vol. 14, pp. 2-19.
Saloma Caesar et al., “Refractive-index measurement at high spatial resolution by source doubling”, Optical Society of America, vol. 19, No. 14, Jul. 15, 1994, pp. 1088-1090.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Non-invasive blood glucose monitoring by interferometry does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-invasive blood glucose monitoring by interferometry, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-invasive blood glucose monitoring by interferometry will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3321143

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.